RankAlpha logo
Back to Rankings

RANI

Rani TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
RANI vs peer average
82/100
RANI vs. peer average (B vs. D)
Grade spread
B 2 · D 5 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

TELO is the first available peer comparator.

Same-sector market-cap comparator; operating and pipeline comparability is limited based on the available packet.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerTELOTelomir
RANI
Rani Therapeutics
TELO
Telomir
Grade
B
F
Momentum
85
26
Value
41
41
Sentiment
57
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs TELO

RANI / TELO
Grade Position
Above peers
RANI vs. peer average (B vs. D)
82/100
Momentum
85
RANI
Value
41
RANI
Sentiment
57
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RANI
1
TELO
TELO
F
20/100
+3
2
ACRV
ACRV
B
80/100
Even
3
RLYB
RLYB
F
20/100
+3
4
KLRS
Kalaris Therapeutics Inc Common
B
80/100
Even
5
VRCA
Verrica Pharmaceuticals Inc Common
D
40/100
+2
TELO is the first peer returned for this comparison set.